Global Male Infertility Market Size, Trends & Growth Opportunity, By Test (DNA Fragmentation Technique, Oxidative Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay, Others), By Treatment (Assisted Reproductive Technology and Varicocele Surgery, Medication), and Forecast till 2027.
Report ID : QR1001501 | Industries : Healthcare | Published On :June 2022 | Page Count : 240Global Male Infertility Market
The global Male Infertility market was valued at USD 4.0 billion in 2021 and it is expected to reach USD 5.9 billion by 2027 from, at a CAGR of 4.9% over the forecast period.
The study includes Male Infertility Market analysis, in which market size, growth rate, and overall attractiveness are evaluated across Test, Treatment. The study comprises both historical data and a revenue forecast. Throughout the forecast period, the report discusses Male Infertility Market drivers and restraints, as well as their impact on demand.
the study includes a competitive landscape & an analysis of Porter's Five Forces model for the industry. The study offers an up-to-date assessment of the current market situation, as well as the recent trends and drivers, as well as the general market environment. The study contains market estimates & assessments on a global and regional scale.
The study presents a thorough picture of Male Infertility Market by segmenting it by Test, Treatment, and region. The research begins by describing the overall scope of the global market, as well as the feasibility of investments in various market segments, as well as a descriptive section which describes the feasibility of new projects that may succeed in the global market in the near future.
Know more about this report: request for sample pages
Competitive Outlook:
mergers and Acquisitions, new technology launches, business expansion, agreements, partnerships, collaborations & joint ventures, research & development, and geographic growth of leading market participants are all covered in this report on a worldwide and regional basis. The study looks at company market share in order to have a better view of the top players in the Male Infertility Market industry. In addition, the study examines price patterns & large firms' product portfolios by area. The study combines data on each of the market's leading players, including current company profiles, gross margins, sales revenue, sales volume, and product specifications.
Key Players:
The key players profiled in the Male Infertility market report include Bayer Healthcare; Andrology solutions; Aytu BioScience, Inc.; Cadila Healthcare Ltd.; Halotech DNA SL; EMD Sereno, Inc.; SCSA Diagnostics, Inc.; Intas Pharmaceuticals Ltd.
Market Taxonomy
By Test
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
- Others
By Treatment
- Assisted Reproductive Technology and Varicocele Surgery
- Medication
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Global Male Infertility Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Tests
3 Executive Summary
4 Global Male Infertility Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Male Infertility Market, By Test
5.1 Y-o-Y Growth Comparison, By Test
5.2 Global Male Infertility Market Share Analysis, By Test
5.3 Global Male Infertility Market Size and Forecast, By Test
5.3.1 DNA Fragmentation Technique
5.3.2 Oxidative Stress Analysis
5.3.3Microscopic Examination
5.3.4 Sperm Agglutination
5.3.5 Computer Assisted Semen Analysis
5.3.6 Sperm Penetration Assay
5.3.7 Others
6 Global Male Infertility Market, By Treatment
6.1 Y-o-Y Growth Comparison, By Treatment
6.2 Global Male Infertility Market Share Analysis, By Treatment
6.3 Global Male Infertility Market Size and Forecast, By Treatment
6.3. 1 Assisted Reproductive Technology and Varicocele Surgery
6.3.2 Medication
7 Global Male Infertility Market, By Region
7.1 Global Male Infertility Market Share Analysis, By Region
7.2 Global Male Infertility Market Share Analysis, By Region
7.3 Global Male Infertility Market Size and Forecast, By Region
8 North America Male Infertility Market Analysis and Forecast (2021-2027)
8.1 Introduction
8.2 North America Male Infertility Market Share Analysis, By Test
8.3 North America Male Infertility Market Size and Forecast, By Treatment
8.4 North America Male Infertility Market Size and Forecast, By Country
8.5.1 U.S.
8.6.2 Canada
9.7.3 Mexico
9 Europe Male Infertility Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 Europe Male Infertility Market Share Analysis, By Test
9.3 Europe Male Infertility Market Size and Forecast, By Treatment
9.4 Europe Male Infertility Market Size and Forecast, By Country
9.5.1 Germany
9.6.2 France
9.7.3 UK
9.8.4. Rest of Europe
10 Asia Pacific Male Infertility Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Asia Pacific Male Infertility Market Share Analysis, By Test
10.3 Asia Pacific Male Infertility Market Size and Forecast, By Treatment
10.4 Asia Pacific Male Infertility Market Size and Forecast, By Country
10.5.1 China
10.6.2 Japan
10.7.3 India
10.8.4. Rest of Asia Pacific
11 Latin America Male Infertility Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Latin America Male Infertility Market Share Analysis, By Test
11.3 Latin America Male Infertility Market Size and Forecast, By Treatment
11.4 Latin America Male Infertility Market Size and Forecast, Country
11.5.1. Brazil
11.6.2. Rest of Latin America
12 Middle East Male Infertility Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Middle East Male Infertility Market Share Analysis, By Test
12.3 Middle East Male Infertility Market Size and Forecast, By Treatment
12.4 Middle East Male Infertility Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.6.2. UAE
12.7.3. Egypt
12.8.4. Kuwait
12.9.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Bayer Healthcare
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Andrology solutions
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Aytu BioScience, Inc.
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Cadila Healthcare Ltd
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 Halotech DNA SL
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 SCSA Diagnostics, Inc
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 EMD Sereno, Inc
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Intas Pharmaceuticals Ltd.
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies